| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/11/2001 | EP0854709B1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 04/11/2001 | EP0662076B1 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 04/11/2001 | EP0517829B1 Improved chimeric toxins |
| 04/11/2001 | CN1291239A Fermentative preparation process for cytostatics and crystal form thereof |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291228A Enzyme catalyzed therapeutic agents |
| 04/11/2001 | CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/11/2001 | CN1291189A 9-aminoacridine derivatives and process for the preparation thereof |
| 04/11/2001 | CN1291185A Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291105A Hapten-modified tumor cell membranes and preparation and method for using it |
| 04/11/2001 | CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 04/11/2001 | CN1290707A Nucleoside 5'-thiophosphoryl amino-acid ester compound |
| 04/11/2001 | CN1290703A New metal protease inhibitors, its preparing method and their medicinal composition containing them |
| 04/11/2001 | CN1290550A Anti-cancer medicinal composition and its preparing method |
| 04/11/2001 | CN1290530A Aitongning plaster for cancer and its preparing method |
| 04/11/2001 | CN1064362C Pyrimido [5,4-D] pyrimidines, medicine containing these compounds, their use and process for their production |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064241C Snake poison anti-cancer medicine and its prepn. |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | US6215000 Crystalline complexes of baccatin III with imidazole, 2-methylimidazole or isopropanol |
| 04/10/2001 | US6214986 Antisense modulation of bcl-x expression |
| 04/10/2001 | US6214978 Antitumor and anticholesterol preparations containing a lipoteichoic acid from streptococcus |
| 04/10/2001 | US6214974 Internalizable cell binding component having biotin binding element conjugated to biotinylated nucleic acids or cytotoxic moieties such as gelonin, ricin, saporin, abrin, diptheria toxin and the like; gene therapy; drug delivery of toxins |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214874 Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
| 04/10/2001 | US6214872 Antiarthritic and anticarcinogenic agents |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214865 Anticancer agent |
| 04/10/2001 | US6214863 Synergistic therapy for breast cancer consisting of taxol or taxotere and derivatives, with alkylating agent such as cyclophosphamide and anthracycline antibiotic (daunorubicin or doxorubicin); avoiding/ delaying multi-drug resistance |
| 04/10/2001 | US6214862 Analyzing proteasome sensitivity proteolysis |
| 04/10/2001 | US6214860 Anticancer agents |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214851 N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent |
| 04/10/2001 | US6214836 Water soluble analogues of 20(S)-camptothecin |
| 04/10/2001 | US6214828 Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease |
| 04/10/2001 | US6214827 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |
| 04/10/2001 | US6214798 Polypeptides |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214567 Testing antitumor agents; obtain preferential human tissue and incubate with antitumor agent, evaluate propagtion of tumorous cells |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | US6214315 Radioactive embolizing compositions |
| 04/10/2001 | CA2222299C Novel taxoids |
| 04/10/2001 | CA2200855C Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/10/2001 | CA2117532C Method of inhibiting carcinogenesis by treatment with dehydropiandrosterone and analogs thereof |
| 04/10/2001 | CA2056412C Discodermolide compounds, compositions containing same and methods of preparation and use |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023588A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023573A1 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023432A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 04/05/2001 | WO2001023431A1 Derivatives of antibody against ganglioside gm2 |
| 04/05/2001 | WO2001023424A1 A phosphatidylethanolamine binding protein (pebp-2) and uses thereof |
| 04/05/2001 | WO2001023422A1 Vaccine |
| 04/05/2001 | WO2001023421A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023391A1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/05/2001 | WO2001023390A2 Azepinoindole derivatives, the production and use thereof |
| 04/05/2001 | WO2001023386A2 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | WO2001023384A1 Antitumor agents |
| 04/05/2001 | WO2001023382A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023363A1 Sulfonamide derivatives |
| 04/05/2001 | WO2001023362A2 Rate-controlled particles |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023359A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023349A1 Acylsulfonamide derivatives |
| 04/05/2001 | WO2001023006A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | WO2001022996A1 Administration of gamma globulins to treat lymphoma |
| 04/05/2001 | WO2001022990A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 04/05/2001 | WO2001022986A1 Anti cancer agent and method of treatment of cancer |
| 04/05/2001 | WO2001022979A1 Method to disrupt mitochondrial function |
| 04/05/2001 | WO2001022974A1 Prevention of colorectal cancer |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022970A1 Therapy with 2-5a and interferon |
| 04/05/2001 | WO2001022968A1 Anticancer agents |
| 04/05/2001 | WO2001022954A2 Indolyl-3-glyoxylic acid derivatives serving as antitumor agents |
| 04/05/2001 | WO2001022922A2 Engineering antibodies that bind irreversibly |
| 04/05/2001 | WO2001022920A2 Colon and colon cancer associated polynucleotides and polypeptides |